Understanding Prevalence Of Rem Sleep Behavior Disorder

REM sleep behaviour disorder (RBD) is a rare condition, affecting between 0.5% and 1% of adults. It is characterised by abnormal behaviours during REM sleep, such as twitching, talking, flailing, kicking, and even jumping out of bed. These behaviours are a result of intense dreams that the person is acting out, and they can cause sleep disruption and injury to the individual or their bed partner. RBD is more common in men and adults over 50, although it can also occur in children in higher-risk groups. The exact cause of RBD is unknown, but it is often associated with other neurological conditions and the use of certain medications.

REM sleep behaviour disorder is relatively rare, affecting between 0.5% and 1% of adults

REM sleep behaviour disorder (RBD) is a rare condition, affecting an estimated 0.5% to 1% of adults. It is characterised by abnormal behaviours during REM sleep, such as acting out dreams, which can cause sleep disruption and injury to oneself or one's bed partner. RBD is often associated with other neurological conditions, particularly neurodegenerative diseases such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. It is also linked to the use of certain medications, including antidepressants, and withdrawal from substances like alcohol.

The exact cause of RBD is unknown, but it typically occurs when the normal muscle paralysis that happens during REM sleep is incomplete or absent. This allows individuals to physically act out their dreams, which are often intense and violent. Symptoms can include minor movements like leg twitches, but can also result in more complex and dangerous behaviours such as shouting, punching, kicking, or jumping out of bed.

RBD is usually diagnosed in middle-aged to elderly individuals and is more common in men. The diagnosis is confirmed through a sleep study, specifically an in-laboratory polysomnography with video recording, which helps identify abnormal behaviours and excludes other sleep disorders. Treatment focuses on injury prevention and managing any underlying conditions, and may include medications such as melatonin or clonazepam.

While RBD is relatively rare in the general population, its prevalence increases significantly in older adults, with estimates ranging from 5% to 13% in adults aged 60 to 99. Among this older population, approximately 60% of cases are idiopathic, while 40% are associated with underlying neurological disorders. The onset of symptoms typically occurs during the sixth or seventh decade of life, and there is a higher prevalence in men compared to women.

RBD is a serious condition that can have dangerous consequences for both the affected individual and their bed partner. The violent nature of the movements during RBD episodes can lead to physical injuries, and even life-threatening situations. Additionally, the sleep disruption caused by RBD can result in relationship problems for those who share a bed with their partner. Therefore, it is crucial to seek medical advice and appropriate treatment to manage the condition and reduce the risk of harm.

The disorder is more common in men and adults over 50

REM sleep behaviour disorder (RBD) is more common in men and adults over 50. The prevalence of RBD in the general population is estimated to be between 0.5% and 1%. However, among adults over 50, this number increases significantly, with RBD presenting in 5% to 13% of adults aged 60 to 99.

Several factors contribute to the higher prevalence of RBD in this age group. One key factor is the association between RBD and certain neurological disorders, such as Parkinson's disease, Lewy body dementia, and multiple system atrophy. These disorders become more prevalent with advancing age, and RBD is often an early sign of their development. In fact, studies have shown that individuals with RBD have an increased risk of developing these neurological disorders later in life. For example, one study found that 38% of people diagnosed with RBD went on to develop Parkinson's disease within an average of 12 to 13 years after the onset of RBD symptoms.

In addition to the link with neurological disorders, the risk factors for RBD include older age and male sex. The average age of onset for RBD is around 61 years, and the disorder is more prevalent in men, with 87% of cases occurring in males. This gender disparity is particularly notable among older adults, with a male predominance in the prevalence of RBD among those over 50.

The reasons for the higher prevalence of RBD in men are not fully understood and require further research. However, it is clear that RBD poses a significant risk to the health and safety of those affected and their bed partners. The disorder can lead to violent and complex behaviours during sleep, such as punching, kicking, and jumping out of bed, which can result in injuries to both the individual and their bed partner. Therefore, the management of RBD focuses on injury prevention, treating coexisting sleep disorders, and pharmacological interventions to reduce symptoms.

RBD is strongly linked to neurodegenerative diseases, such as Parkinson's disease

Rapid eye movement (REM) sleep behaviour disorder (RBD) is a parasomnia characterised by excessive muscle activity during REM sleep, which is typically associated with unpleasant dreams and dream enactment behaviour (DEB). RBD is strongly linked to neurodegenerative diseases, such as Parkinson's disease.

The prevalence of RBD in the general population is estimated to be between 0.38% and 2.01%, but this figure is much higher in patients with neurodegenerative diseases, especially synucleinopathies. The frequency of RBD is estimated to be 33–60% in Parkinson's disease patients, 50–80% in Lewy body dementia patients, and 80–95% in multiple system atrophy patients. RBD often occurs several years before the development of these neurodegenerative diseases. In one study, 38% of people diagnosed with RBD developed Parkinson's disease within an average of 12 to 13 years after the onset of RBD symptoms. Another study found that the risk for RBD patients to develop a neurodegenerative disease over a long-term follow-up is more than 90%. This suggests that RBD may be used as an early marker of neurodegenerative diseases.

The link between RBD and neurodegenerative diseases is not fully understood, but several theories have been proposed. One theory suggests that RBD may be a precursor or early symptom of neurodegenerative diseases, especially Parkinson's disease. This is supported by the fact that RBD often precedes the onset of neurodegenerative diseases by several years. Another theory suggests that RBD and neurodegenerative diseases may share common underlying pathophysiological mechanisms, such as the accumulation of alpha-synuclein protein in neurons. This is known as the "synucleinopathy hypothesis".

The treatment of RBD in the context of neurodegenerative diseases is challenging due to the complex nature of these disorders. However, several pharmaceutical treatments are available, including clonazepam, melatonin, pramipexole, and other newly reported medications. Additionally, the understanding of the link between RBD and neurodegenerative diseases has important implications for the diagnosis and management of these conditions. The presence of RBD may be a useful marker for the early detection and monitoring of neurodegenerative diseases, allowing for more timely and effective interventions.

RBD can be caused by antidepressant use or withdrawal from drugs or alcohol

Antidepressants are among the most commonly prescribed medications, and they can trigger symptoms of REM sleep behaviour disorder (RBD) in up to 6% of users. This is particularly common in older patients. The reason for this connection is unclear, but it is thought that antidepressants may cause an RBD-like disorder that is completely independent of associated synucleinopathy, or that they trigger an RBD that is subclinical, resulting in an earlier clinical presentation than would otherwise have occurred.

The neurotransmitter dopamine plays a key role in REM sleep and muscle paralysis during that sleep stage. Antidepressants that increase dopamine levels or dopamine receptor binding may disrupt this paralysis and allow for excess movement and dream enactment. Tricyclic antidepressants like amitriptyline and the NDRI bupropion have been associated with a higher risk of RBD.

Withdrawal from drugs or alcohol can also cause or worsen RBD. Alcohol withdrawal can cause restlessness during sleep and make people more prone to nightmares and RBD. Marijuana can initially decrease episodes of acting out dreams, but this can have a backlash effect, causing symptoms to re-emerge and worsen over time.

Diagnosis of RBD requires confirmation by a sleep study

The diagnosis of RBD requires confirmation by an in-laboratory sleep study (polysomnography) with video recording. This is because RBD is characterised by abnormal behaviours during REM sleep, and a sleep study helps assert these abnormal behaviours and excludes other sleep disorders.

Polysomnography involves simultaneously recording many physiological variables, including electroencephalography (EEG). This means that home sleep tests cannot be used. PSG is also helpful in excluding other sleep disorders such as sleep-disordered breathing, seizure, and other non-REM sleep disorders or parasomnia. In cases when abnormal behaviour does not occur during the sleep study, REM sleep without atonia is required for the diagnosis.

The International Classification of Sleep Disorders, 3rd edition, states that diagnostic criteria for RBD must include the following:

• Repeated episodes of sleep-related vocalisation and/or complex motor behaviours.
• Documenting behaviours by polysomnography during REM sleep or based on clinical history.
• Recordings of polysomnography that demonstrate REM sleep without atonia via submental or limb leads.
• Behaviours are not better explained by another sleep disorder, mental disorder, medication, substance use, or epilepsy.

Validated questionnaires have also been established to screen patients for RBD. However, these only enable diagnosis of probable RBD.

Frequently asked questions